Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8133890 | Combination of brimonidine and timolol for topical ophthalmic use Disclosed are pharmaceutical compositions comprising brimondine and timolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated for glaucoma and associated conditions such as elevated intraocular pressur... | 03/13/2012 |
| 7923469 | Compositions including vitamin-based surfactants and methods for using same Compositions for caring for contact lenses and eyes include a liquid aqueous medium and a vitamin derivative component present in an amount effective as a surfactant in the composition. The compositions can be used to clean, soak, re-wet and, with the inclusion of a... | 04/12/2011 |
| 7579481 | Method of making imidazole-2-ones and 2-thiones A method of 4-substituted imidazole-2-ones and thiones which comprises reacting a methylene urea or methylene thiourea wherein said methylene is substituted with the 4-subsituent and a cyano or alkycarboxylate group to provide said 4-substituted imidazole 2-one or t... | 08/25/2009 |
| 7576112 | Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives A compound having a structure and therapeutic methods, compositions, and medicaments related thereto are disclosed herein. ... | 08/18/2009 |
| 7569595 | 2-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one A compound of the formula or a pharmaceutically acceptable salt thereof, is disclosed herein. Methods and compositions related thereto are also disclosed. ... | 08/04/2009 |
| 7569584 | 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alphaagonist and methods of using the same The compound of the formula wherein the * indicates an asymmetric carbon, is specific to alpha2B adrenergic receptors in preference over alpha2A and alpha2C adrenerg... | 08/04/2009 |
| 7557095 | Therapeutic compounds Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt thereof, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed. ... | 07/07/2009 |
| 7553860 | Substituted gamma lactams as therapeutic agents A compound having the formula or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds ar... | 06/30/2009 |
| 7550502 | Substituted gamma lactams as therapeutic agents A compound comprising or a pharmaceutically acceptable salt thereof, or a prodrug thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds a... | 06/23/2009 |
| 7550448 | Therapeutic compounds Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed. ... | 06/23/2009 |
| 7547727 | Therapeutic cyclopentane derivatives Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed. ... | 06/16/2009 |
| 7547685 | Therapeutic substituted pyrrolidone compounds Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof are disclosed herein. Details are provided herein. Compositions, methods, and medicaments related thereto are also disclosed. ... | 06/16/2009 |
| 7534795 | Compounds and their use related to compositions for treating disease Novel compounds and their uses are disclosed herein. ... | 05/19/2009 |
| 7514462 | ω-Cycloalkyl 17-heteroaryl prostaglandin Eanalogs as EP-receptor agonists The invention relates to the use of derivatives of E-type prostaglandins as EP2 agonists, in general, and, in particular as ocular hypotensives. The PGE derivatives used in accordance with the invention are represented by the following formula I: | 04/07/2009 |
| 7507833 | Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives A compound having a structure and therapeutic methods, compositions, and medicaments related thereto are disclosed herein. ... | 03/24/2009 |
| 7507817 | Prostaglandin prodrugs Novel compounds, and therapeutic methods, compositions and medicament related thereto are disclosed herein. ... | 03/24/2009 |
| 7498447 | Therapeutic compounds Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed. ... | 03/03/2009 |
| 7491844 | Therapeutic cyclopentane derivatives Described herein are compounds having a formula and therapeutic methods, compositions, and medicaments, related thereto. ... | 02/17/2009 |
